Holmium-166 Radioembolization in Hepatocellular Carcinoma: Feasibility and Safety of a New Treatment Option in Clinical Practice.

导出原文传递

翻译打印收藏纠错

第一作者： Christoph G,Radosa

第一单位： Institute and Policlinic for Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany.

作者： Christoph G,Radosa ^[1] ; Julia C,Radosa ^[2] ; Sabine,Grosche-Schlee ^[3] ; Klaus,Zöphel ^[3] ; Verena,Plodeck ^[1] ; Jens P,Kühn ^[1] ; Jörg,Kotzerke ^[3] ; Ralf-Thorsten,Hoffmann ^[4]

作者单位： Institute and Policlinic for Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. ^[1] Department of Gynecology and Obstetrics, Saarland University Hospital, Kirrbergerstraße 100, 66421, Homburg, Germany. ^[2] Department of Nuclear Medicine, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. ^[3] Institute and Policlinic for Diagnostic and Interventional Radiology, University Hospital Carl Gustav Carus, TU Dresden, Fetscherstraße 74, 01307, Dresden, Germany. ralf-thorsten.hoffmann@uniklinikum-dresden.de. ^[4]

关键词 Cirrhosis HCC Hepatocellular carcinoma Holmium Liver Microspheres REILD RILD Radioembolization Radioembolization-induced liver disease SIRT